CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The compa… Read more
CS Diagnostics Corp. (CSDX) - Total Assets
Latest total assets as of September 2025: $499.43 Million USD
Based on the latest financial reports, CS Diagnostics Corp. (CSDX) holds total assets worth $499.43 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
CS Diagnostics Corp. - Total Assets Trend (None–None)
This chart illustrates how CS Diagnostics Corp.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
CS Diagnostics Corp. - Asset Composition Analysis
Asset Composition Trend (None–None)
This chart illustrates how CS Diagnostics Corp.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Asset Diversification: The largest asset category is goodwill at % of total assets.
CS Diagnostics Corp. Competitors by Total Assets
Key competitors of CS Diagnostics Corp. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
CS Diagnostics Corp. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - CS Diagnostics Corp. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - CS Diagnostics Corp. is currently not profitable relative to its asset base.
CS Diagnostics Corp. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 19.27 | - | - |
| Quick Ratio | 19.27 | - | - |
| Cash Ratio | 0.00 | - | - |
| Working Capital | $29.40K | - | - |
CS Diagnostics Corp. - Advanced Valuation Insights
This section examines the relationship between CS Diagnostics Corp.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | |
| Asset Growth Rate (YoY) | % |
| Total Assets | $- |
| Market Capitalization | $- USD |
Valuation Analysis
Below Book Valuation: The market values CS Diagnostics Corp.'s assets below their book value ( x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: CS Diagnostics Corp.'s assets decreased by % over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for CS Diagnostics Corp. (None–None)
The table below shows the annual total assets of CS Diagnostics Corp. from None to None.
| Year | Total Assets | Change |
|---|---|---|
| No yearly data available. | ||